Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros











Intervalo de año de publicación
1.
Skin Appendage Disord ; 5(6): 386-389, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31799269

RESUMEN

Cutaneous manifestations of tuberculosis (TB) are rare, particularly from an exogenous source. Involvement of the nail apparatus is extremely rare and has only previously been reported as a secondary involvement. We report the case of a 76-year-old female patient referred to our department with onychodystrophy with purulent drainage of the first left finger, which had developed during the preceding year. She had no previous traumatic history and had received treatment with multiple cycles of oral antibiotics and antimycotics, with no clinical improvement. Physical examination showed paronychia and onychodystrophy of the entire nail plate. Biopsy evaluation revealed epithelioid granulomas with central foci of necrosis, and laboratory cultures were positive for Mycobacterium tuberculosiscomplex. Chest computed tomography excluded primary pulmonary TB. X-ray of the left hand revealed the presence of dactylitis on the distal phalanx. Based on these findings, the patient was treated with rifampicin, isoniazid, pyrazinamide, and ethambutol for 2 months and with rifampicin and isoniazid for 7 months, resulting in complete resolution of the lesions. Cutaneous TB is a diagnostic challenge, particularly in rare cases such as involvement of the nail apparatus. It should be considered as a diagnostic hypothesis in cases of painless paronychia with refractory purulent drainage and associated onychodystrophy.

2.
Artículo en Inglés | MEDLINE | ID: mdl-30901061

RESUMEN

INTRODUCTION: Erythematotelangiectatic rosacea is a common condition in Caucasians. The most frequently used lasers to treat this condition are pulsed dye laser (PDL) and neodymium:yttrium-aluminum-garnet laser (Nd:YAG). This study compares the treatment efficacy of purpuragenic PDL with that of sequential emission of 595 nm PDL and 1,064 nm Nd:YAG (multiplexed PDL/Nd:YAG). METHODS: We performed a prospective, randomized, and controlled split-face study. Both cheeks were treated, with side randomization to receive treatment with PDL or multiplexed PDL/Nd:YAG. Efficacy was evaluated by spectrophotometric measurement, visual photograph evaluation, the Dermatology Quality of Life Index questionnaire, and a post-treatment questionnaire. RESULTS: Twenty-seven patients completed the study. Treatment was associated with a statistically significant improvement in quality of life (p < 0.001). PDL and multiplexed PDL/Nd:YAG modalities significantly reduced the erythema index (EI; p < 0.05). When comparing the degree of EI reduction, no differences were observed between the two treatment modalities. PDL was associated with a higher degree of pain and a higher percentage of purpura. Multiplexed PDL/Nd:YAG modality was associated with fewer side effects and greater global satisfaction, and 96.3% of the patients would recommend this treatment to a friend. CONCLUSIONS: Both laser modalities are efficacious in the treatment of erythematotelangiectatic rosacea. The multiplexed PDL/Nd:YAG modality was preferred by the patients.


Asunto(s)
Dermatosis Facial/radioterapia , Láseres de Colorantes/uso terapéutico , Láseres de Estado Sólido/uso terapéutico , Terapia por Luz de Baja Intensidad/métodos , Satisfacción del Paciente/estadística & datos numéricos , Rosácea/radioterapia , Método Doble Ciego , Estética , Dermatosis Facial/patología , Dermatosis Facial/fisiopatología , Femenino , Humanos , Masculino , Estudios Prospectivos , Calidad de Vida , Medición de Riesgo , Rosácea/patología , Rosácea/fisiopatología , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
3.
Photodiagnosis Photodyn Ther ; 25: 414-416, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30721758

RESUMEN

BACKGROUND: Daylight photodynamic therapy (PDT) has been reported as having similar efficacy to conventional photodynamic therapy in actinic keratosis treatment. METHODS: 25 patients with actinic keratosis of the scalp and/or face were submitted to a daylight photodynamic therapy session. Adverse reactions were evaluated after one week and efficacy after 3 months. Confocal Microscopy was performed in 6 patients, before and one week after the treatment. Our aim was to compare our results with others studies and analyse the changes occurring in the epidermis and upper dermis with confocal microscopy. RESULTS: 76% of the patients were male. The mean age was 74.2 years. In 51.7% of patients the treatment site was the scalp. Mean cure rate at 3 months was 74%. Aesthetic results were excellent in all patients and only one patient reported mild pain during the 2 h exposure. Confocal Microscopy showed a normalization of the honeycomb pattern in all of the patients. CONCLUSIONS: This therapy has similar results to conventional photodynamic therapy and stands out for less discomfort, fewer adverse effects and better cost-effectiveness. Using confocal microscopy it's possible to in vivo demonstrate the efficacy of this method, with normalization of the honeycomb pattern in the epidermis following succcessful PDT.


Asunto(s)
Ácido Aminolevulínico/uso terapéutico , Queratosis Actínica/tratamiento farmacológico , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/uso terapéutico , Luz Solar , Anciano , Anciano de 80 o más Años , Cara , Femenino , Humanos , Masculino , Microscopía Confocal , Cuero Cabelludo , Índice de Severidad de la Enfermedad
4.
Dermatol Online J ; 25(1)2019 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-30710900

RESUMEN

Bullous lupus erythematosus is a rare clinical form of lupus. The diagnosis is challenging and involves the exclusion of other subepidermal bullous dermatoses. We present a 21-year-old woman with erythematosus, polycyclic plaques with vesiculobullae along the periphery, creating an erythema gyratum repens-like pattern on acral regions. The cutaneous biopsy, analytical, and autoimmune studies support the diagnosis of systemic lupus erythematosus. Dapsone and glucocorticosteroids were given with prompt resolution of the lesions within two weeks. To our knowledge this is the first case of bullous lupus erythematosus with this atypical acral presentation.


Asunto(s)
Dermatosis del Pie/diagnóstico , Dermatosis de la Mano/diagnóstico , Dermatosis de la Pierna/diagnóstico , Lupus Eritematoso Sistémico/diagnóstico , Enfermedades Cutáneas Vesiculoampollosas/diagnóstico , Antiinfecciosos/uso terapéutico , Dapsona/uso terapéutico , Eritema , Femenino , Dermatosis del Pie/tratamiento farmacológico , Dermatosis del Pie/etiología , Dermatosis del Pie/patología , Glucocorticoides/uso terapéutico , Dermatosis de la Mano/tratamiento farmacológico , Dermatosis de la Mano/etiología , Dermatosis de la Mano/patología , Humanos , Dermatosis de la Pierna/tratamiento farmacológico , Dermatosis de la Pierna/etiología , Dermatosis de la Pierna/patología , Lupus Eritematoso Sistémico/complicaciones , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/patología , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/etiología , Enfermedades Cutáneas Vesiculoampollosas/patología , Adulto Joven
5.
Artículo en Inglés | MEDLINE | ID: mdl-30564834

RESUMEN

This case study describes a 37-year-old Caucasian male with pruritic papules and plaques-some with central erosion-on the arms, neck, and trunk that appeared after chemotherapy with FOLFOX (folinic acid, fluorouacil, and oxiliplatin) for colon cancer. A histological examination showed features of neutrophilic eccrine hidradenitis. To the best of our knowledge, this is the first reported case of neutrophilic eccrine hidradenitis due to FOLFOX.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias del Colon/tratamiento farmacológico , Hidradenitis/inducido químicamente , Hidradenitis/diagnóstico , Adulto , Fluorouracilo/uso terapéutico , Hidradenitis/terapia , Humanos , Leucovorina/uso terapéutico , Masculino , Compuestos Organoplatinos/uso terapéutico
7.
An Bras Dermatol ; 90(2): 262-4, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25831002

RESUMEN

Lymphangiomas are congenital lymphatic malformations and cutaneous lymphangioma circumscriptum is the most common type. It is clinically characterized by clusters of translucent vesicles and the presence of dermoscopically yellow lacunae surrounded by pale septa, as well as reddish to bluish lacunae. In our case, the recently described hypopyon-like feature manifested, aiding in the sometimes difficult differential diagnosis of cutaneous lymphangioma circumscriptum with vascular lesions, further highlighting the importance of dermoscopy in what can be a diagnostic challenge.


Asunto(s)
Linfangioma/patología , Neoplasias Cutáneas/patología , Adolescente , Axila , Dermoscopía , Diagnóstico Diferencial , Humanos , Masculino , Malformaciones Vasculares/patología
8.
An. bras. dermatol ; 90(2): 262-264, Mar-Apr/2015. graf
Artículo en Inglés | LILACS | ID: lil-741066

RESUMEN

Lymphangiomas are congenital lymphatic malformations and cutaneous lymphangioma circumscriptum is the most common type. It is clinically characterized by clusters of translucent vesicles and the presence of dermoscopically yellow lacunae surrounded by pale septa, as well as reddish to bluish lacunae. In our case, the recently described hypopyon-like feature manifested, aiding in the sometimes difficult differential diagnosis of cutaneous lymphangioma circumscriptum with vascular lesions, further highlighting the importance of dermoscopy in what can be a diagnostic challenge.


Asunto(s)
Adolescente , Humanos , Masculino , Linfangioma/patología , Neoplasias Cutáneas/patología , Axila , Dermoscopía , Diagnóstico Diferencial , Malformaciones Vasculares/patología
9.
Acta Dermatovenerol Croat ; 20(3): 175-80, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23069303

RESUMEN

Tumor necrosis factor alfa (TNF-α) is a cytokine with a central role in inflammation. Its blockade can be achieved by using specific inhibitors like etanercept. At present, etanercept is approved for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis and psoriasis treatment. However, it has been used with promising results in other inflammatory dermatoses. A case is presented of a 54-year-old man diagnosed with pyoderma gangrenosum. He completed treatment with oral prednisolone with favorable outcome, but with recurrence after glucocorticoid therapy withdrawal. Thalidomide was introduced, but after complaints of glove and sock paresthesia and hypoesthesia, the drug was discontinued. Taking into account the favorable outcome with thalidomide and the necessity of drug withdrawal, it was decided to introduce therapy acting on the same step in the inflammation cascade. In this regard, etanercept was initiated. The aim of this article is to present an alternative therapy for refractory pyoderma gangrenosum, along with a literature review.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Inmunoglobulina G/uso terapéutico , Inmunosupresores/uso terapéutico , Piodermia Gangrenosa/tratamiento farmacológico , Receptores del Factor de Necrosis Tumoral/uso terapéutico , Talidomida/uso terapéutico , Etanercept , Humanos , Masculino , Persona de Mediana Edad , Piodermia Gangrenosa/patología
11.
Dermatol Online J ; 17(7): 12, 2011 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-21810397

RESUMEN

Collision tumor is a term used to refer to the association of various types of tumors in time and space. Despite most of them not being clinically relevant, sometimes there is a union between a benign lesion and a malignant one. The clinical diagnosis in these cases is usually extremely difficult, particularly if one of the lesions is pigmented. Dermoscopy and confocal microscopy are noninvasive diagnostic methods that make possible the visualization of morphologic structures not visible to the naked eye, thus making diagnosis of these lesions possible. Here we describe a case in which the corrected diagnosis of a collision between a seborrheic keratosis and a basal cell carcinoma was only possible by means of confocal microscopy.


Asunto(s)
Carcinoma Basocelular/patología , Queratosis Seborreica/patología , Neoplasias Cutáneas/patología , Carcinoma Basocelular/complicaciones , Dermoscopía , Femenino , Humanos , Queratosis Seborreica/complicaciones , Microscopía Confocal , Neoplasias Cutáneas/complicaciones
13.
Acta Med Port ; 23(2): 259-62, 2010.
Artículo en Portugués | MEDLINE | ID: mdl-20470474

RESUMEN

We present the case of a 84 year-old man from north Portugal with chronic myelomonocytic leukaemia (diagnosed 2 years ago), treated with erythropoietin and hydroxyurea. The patient was referred to our department due to brown macules, papules and patches with a smooth surface and whitish scaling, located in the lower limbs that had appeared two months ago. The diagnosis of Kaposi's sarcoma was histologically confirmed. He was HIV-1/HIV-2 negative and had no analytic detectable immussupression. The patient died a short time after the diagnosis before we could start treatment.


Asunto(s)
Leucemia Mielomonocítica Crónica/complicaciones , Sarcoma de Kaposi/etiología , Neoplasias Cutáneas/etiología , Anciano de 80 o más Años , Resultado Fatal , Humanos , Masculino
16.
Dermatol Online J ; 15(4): 2, 2009 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-19450395

RESUMEN

An 84-year-old man with keloids since early adulthood, was referred to our clinic because of the recent appearance of erythematous, tumid plaques upon the old keloids and upon uninvolved skin. The plaques were located mainly on the trunk in a linear distribution. On the back there were round, nodular, erythematous nodules and plaques, with central crusts, that had just appeared on normal skin. A skin biopsy was performed on the plaques that appeared over the older lesions. The histological appearance was consistent with keloid. Similar histology was found in a biopsy taken from a plaque that had erupted on normal skin.


Asunto(s)
Queloide/patología , Anciano de 80 o más Años , Cicatriz/patología , Diagnóstico Diferencial , Estudios de Seguimiento , Humanos , Queloide/diagnóstico , Linfoma Cutáneo de Células T/diagnóstico , Masculino , Recurrencia , Sarcoidosis/diagnóstico , Factores de Tiempo
17.
J Cosmet Laser Ther ; 11(3): 139-41, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19462330

RESUMEN

BACKGROUND: Rosacea is a chronic inflammatory eruption of the face that may significantly impair patients' lives, leading to considerable emotional distress and behavioral withdrawal from normal social interactions. The pulsed dye laser is a device that selectively targets oxyhemoglobin with proved efficacy in the treatment of vascular lesions, especially at purpuric doses. OBJECTIVE: We decided to evaluate the impact of the pulsed dye laser on rosacea patients' quality of life using the Dermatology Life Quality Index (DLQI) score. METHODS: Twenty-two patients with erythematotelangiectatic rosacea were enrolled in the study. They were asked to complete a DLQI questionnaire before and after three treatments. Erythema improvement was subjectively evaluated by two investigators who ranked it as equal, better or worse after the three treatments. RESULTS: A statistically significant improvement was observed in the DLQI score after three treatment sessions. All patients were judged by the investigators to have improved facial erythema. CONCLUSION: This study reinforces the idea that pulsed dye laser usage for the treatment of erythematotelangiectatic rosacea is very efficient, emphasizing that it also has the ability to improve rosacea patients' quality of life.


Asunto(s)
Láseres de Colorantes , Calidad de Vida , Rosácea/cirugía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Rosácea/psicología
18.
Eur J Dermatol ; 19(3): 248-51, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19258241

RESUMEN

Erlotinib and cetuximab are human epidermal growth factor receptor inhibitors (EGFRI) that are approved in monotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Papulopustular eruptions are the most frequent adverse effect, their occurrence being associated with increased survival in some studies. We describe 19 patients who presented with a rash located mainly to the face and trunk, without presence of comedones, shortly after initiation of EGFRI therapy. We present our algorithm to manage these patients and their respective responses. We also report other therapeutic options and cutaneous alterations that may be seen.


Asunto(s)
Erupciones Acneiformes/inducido químicamente , Anticuerpos Monoclonales/efectos adversos , Antineoplásicos/efectos adversos , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Pulmonares/tratamiento farmacológico , Inhibidores de Proteínas Quinasas/efectos adversos , Quinazolinas/efectos adversos , Erupciones Acneiformes/diagnóstico , Erupciones Acneiformes/prevención & control , Anciano , Anciano de 80 o más Años , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales Humanizados , Antineoplásicos/administración & dosificación , Cetuximab , Receptores ErbB/antagonistas & inhibidores , Clorhidrato de Erlotinib , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Inhibidores de Proteínas Quinasas/administración & dosificación , Quinazolinas/administración & dosificación , Índice de Severidad de la Enfermedad
20.
Dermatol Online J ; 14(2): 9, 2008 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-18700112

RESUMEN

Chromoblastomycosis is a rare, hard to diagnose disease that arises mostly in the tropics, especially in humid areas, affecting mainly males and rural workers. It is characterized by verrucous plaques or nodules that are slow growing and attributed to infection by different pigmented (dematiaceous) fungi. Usually the infection develops after injury, being primarily located on the lower extremities. The authors present the case of a healthy, 60-year-old man observed with a one year history of an erythematous violaceous 5cm tumor located on the right thigh. A biopsy specimen for histopathology revealed single or clustered brown pigmented cells, with a single or double septum and thick cell walls. Cultural smears showed growth of Fonsecaea Pedrosoi. The patient was treated with oral itraconazole (200mg per day), with a good response and clinical cure in 6 months that left only an atrophic scar.


Asunto(s)
Cromoblastomicosis/etiología , Enfermedades Profesionales/etiología , Madera/microbiología , Antifúngicos/uso terapéutico , Ascomicetos/aislamiento & purificación , Cromoblastomicosis/diagnóstico , Cromoblastomicosis/tratamiento farmacológico , Cromoblastomicosis/microbiología , Humanos , Itraconazol/uso terapéutico , Masculino , Persona de Mediana Edad , Hongos Mitospóricos/aislamiento & purificación , Enfermedades Profesionales/diagnóstico , Enfermedades Profesionales/tratamiento farmacológico , Enfermedades Profesionales/microbiología , Portugal , Muslo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA